Injective price prediction: More downside ahead? INJ drops 7.17% on seller pressure
Injective (INJ) is trading at $5.44, positioned below the MA-20 ($5.71), MA-50 ($6.74), and MA-200 ($11.14), signaling persistent bearish momentum across all key timeframes.
Highlights
- INJ trades at $5.44, remaining below the MA-20 ($5.71), MA-50 ($6.74), and MA-200 ($11.14), confirming ongoing bearish momentum across all timeframes.
- Daily indicators show strong sell signals as MACD, ADX, and RSI (43.46) affirm downside pressure, while intraday trading posted a 7.17% drop and high volatility.
- INJ is expected to consolidate between $5.10 and $5.65 over the next five days, with less than 20% probability of a price increase and further downside likely.
Resistance at Kijun with negative momentum despite intraday buying
The nearest dynamic resistance is marked by the Ichimoku Kijun at $6.01, with no immediate support from Ichimoku visible in the current range; price continues to trade beneath all major moving averages, confirming seller dominance. Momentum indicators on the daily chart point to prevailing downside pressure: MACD shows a strong sell and ADX signals a weak trend, while RSI (43.46) moves in bearish territory. Stochastic RSI is flagged as overbought, indicating potential for further decline or correction, and the CCI remains neutral, highlighting mixed short-term sentiment. BBP reads positive at 0.36 (Buy), suggesting some buyer interest intraday, but today’s trading has been sharply negative with a 7.17% drop; there was no notable gap at the open, and the price sits near the lower end of today's $5.30 – $5.65 range, reflecting high intraday volatility and renewed sell pressure after the open. While BBP hints at buyer attempts, the overall daily momentum stays firmly bearish — with oscillators and momentum tools showing some divergence as buyers resist but sellers remain dominant.
Downside bias prevails as consolidation likely without breakout
For the next five trading days, the expected price range is $5.06 – $5.68. The probability of a further price increase is very low (less than 20%), making a move lower more likely given the prevailing momentum and higher timeframe signals. Baseline scenario sets INJ consolidating between $5.10 and $5.65 as market participants await clearer signals. Bullish scenario: a break above $6.01 (Kijun resistance) could pave the way for a short-term rebound toward $6.50; bearish scenario: sustained weakness below $5.30 could trigger accelerated selling toward weekly support near $5.10.
Previously it was reported that Injective was trading just below its short-term moving average and well beneath both the MA-50 and MA-200, reflecting ongoing bearish sentiment due to persistent weakness in technical indicators such as the MACD, RSI, and ADX. As the asset approached a key support zone amid high intraday volatility and mixed oscillator signals, sideways consolidation between support and resistance was expected unless momentum dynamics shifted significantly.
- Forex
- Crypto